William Blair Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $20.6M | Buy |
|
|||||
|
2024
Q2 | $17.1M | Buy |
|
|||||
|
2024
Q1 | $13.8M | Buy |
|
|||||
|
2023
Q4 | $13.4M | Buy |
|
|||||
|
2023
Q3 | $9.57M | Buy |
|
|||||
|
2023
Q2 | $11.2M | Buy |
|
|||||
|
2023
Q1 | $11.2M | Buy |
|
|||||
|
2022
Q4 | $9.43M | Sell |
|
|||||
|
2022
Q3 | $35.9M | Buy |
|
|||||
|
2022
Q2 | $35.3M | Sell |
|
|||||
|
2022
Q1 | $103M | Sell |
|
|||||
|
2021
Q4 | $216M | Buy |
|
|||||
|
2021
Q3 | $192M | Buy |
|
|||||
|
2021
Q2 | $164M | Sell |
|
|||||
|
2021
Q1 | $197M | Sell |
|
|||||
|
2020
Q4 | $203M | Buy |
|
|||||
|
2020
Q3 | $181M | Buy |
|
|||||
|
2020
Q2 | $166M | Sell |
|
|||||
|
2020
Q1 | $111M | Buy |
|
|||||
|
2019
Q4 | $148M | Buy |
|
|||||
|
2019
Q3 | $133M | Buy |
|
|||||
|
2019
Q2 | $102M | Buy |
|
|||||
|
2019
Q1 | $112M | Sell |
|
|||||
|
2018
Q4 | $133M | Sell |
|
|||||
|
2018
Q3 | $283M | Sell |
|
|||||
|
2018
Q2 | $236M | Buy |
|
|||||
|
2018
Q1 | $170M | Sell |
|
|||||
|
2017
Q4 | $170M | Buy |
|
|||||
|
2017
Q3 | $156M | Sell |
|
|||||
|
2017
Q2 | $215M | Buy |
|
|||||
|
2017
Q1 | $183M | Buy |
|
|||||
|
2016
Q4 | $123M | Buy |
|
|||||
|
2016
Q3 | $100M | Sell |
|
|||||
|
2016
Q2 | $150M | Buy |
|
|||||
|
2016
Q1 | $132M | Buy |
|
|||||
|
2015
Q4 | $124M | Sell |
|
|||||
|
2015
Q3 | $116M | Buy |
|